Tailored Bacteriocin Solutions for Niche Environments

The present inventive concept provides specialized bacteriocin compositions and methods for tackling microbial growth in unique operational environments, such as high-security facilities, disaster relief scenarios, extreme weather conditions, and agricultural water sources.

The original patent disclosed therapeutic bacteriocins effective against Klebsiella pneumoniae and Escherichia coli. However, these bacteriocins may not be suitable for specific, high-stakes applications requiring tailored formulations and delivery methods. The present inventive concept addresses this limitation by adapting the bacteriocin technology for niche markets and environments, thereby expanding its utility and impact.

The inventive concept encompasses bacteriocin compositions with receptor-mediated translocation domains and killing domains, formulated for specific delivery methods and environments. For example, Claim 1 describes a system for treating high-security biohazard facilities using an aerosol-delivered bacteriocin effective against Gram-negative bacteria in high-temperature environments. Similarly, Claim 2 discloses a method for disaster relief, where a bacteriocin with a labeling domain selectively targets and labels Gram-negative bacteria in contaminated water sources, enabling efficient removal. The inventive concept also includes compositions for treating skin infections in extreme weather conditions (Claim 3) and systems for treating agricultural water sources (Claim 4), as well as methods for treating medical devices in high-security facilities (Claim 5).

The inventive concept's novelty lies in its specialized formulations and delivery methods, which are tailored to address the unique challenges of specific operational environments. The inventive step resides in the recognition of the need for adapted bacteriocin solutions and the development of compositions and methods that effectively target microbial growth in these niche contexts.

Alternative embodiments may include bacteriocin compositions with additional domains or functionalities, such as enhanced stability or targeting capabilities. Variations may also involve different delivery methods, such as injectable or oral formulations, or adaptations for use in other specialized environments, such as space exploration or military operations.

The inventive concept has significant commercial potential in various industries, including biodefense, disaster relief, agriculture, and healthcare. The targeted solutions offered by this technology can provide a competitive edge in these markets, addressing specific pain points and unmet needs.